Capital expenditure increased 101.0%
Capital expenditure changed +101.0% from the comparable as-filed period.
$105.0M→$211.0M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →STX financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Total assets increased 22.3%
Total assets changed +22.3% from the comparable as-filed period.
$8.4B→$10.3B3 prior comparisons
Current liabilities decreased 27.9%
Current liabilities changed -27.9% from the comparable as-filed period.
$4.1B→$3.0B3 prior comparisons
Working capital / assets moved 2452 bp higher
Working capital / assets changed +2452 basis points from the comparable as-filed period.
-1.01%→23.51%3 prior comparisons
Current ratio increased 85.6%
Current ratio changed +85.6% from the comparable as-filed period.
0.98→1.823 prior comparisons
Debt / assets moved 3639 bp lower
Debt / assets changed -3639 basis points from the comparable as-filed period.
59.16%→22.77%3 prior comparisons
Debt / revenue moved 13442 bp lower
Debt / revenue changed -13442 basis points from the comparable as-filed period.
189.96%→55.54%2 prior comparisons
Operating cash-flow margin moved 1969 bp higher
Operating cash-flow margin changed +1969 basis points from the comparable as-filed period.
20.24%→39.92%2 prior comparisons
Cash / debt moved 3124 bp higher
Cash / debt changed +3124 basis points from the comparable as-filed period.
22.27%→53.51%2 prior comparisons
Free-cash-flow margin moved 1870 bp higher
Free-cash-flow margin changed +1870 basis points from the comparable as-filed period.
16.24%→34.94%2 prior comparisons
R&D / revenue moved 235 bp lower
R&D / revenue changed -235 basis points from the comparable as-filed period.
7.07%→4.72%2 prior comparisons
Cost of revenue increased 13.4%
Cost of revenue changed +13.4% from the comparable as-filed period.
$1.6B→$1.8B2 prior comparisons
Receivables / revenue moved 211 bp higher
Receivables / revenue changed +211 basis points from the comparable as-filed period.
40.81%→42.92%2 prior comparisons
Stockholders' equity changed across a sign change
Stockholders' equity changed +5581.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$63.0M→$3.5B2 prior comparisons
Working capital changed across a sign change
Working capital changed +2956.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$85.0M→$2.4B3 prior comparisons
Stock-based compensation increased 21.2%
Stock-based compensation changed +21.2% from the comparable as-filed period.
$52.0M→$63.0M2 prior comparisons
Cash & equivalents increased 13.1%
Cash & equivalents changed +13.1% from the comparable as-filed period.
$1.1B→$1.3B2 prior comparisons
Capex / revenue moved 99 bp higher
Capex / revenue changed +99 basis points from the comparable as-filed period.
3.99%→4.98%2 prior comparisons
Inventory increased 13.6%
Inventory changed +13.6% from the comparable as-filed period.
$1.5B→$1.7B3 prior comparisons
Research & development increased 7.5%
Research & development changed +7.5% from the comparable as-filed period.
$186.0M→$200.0M2 prior comparisons
Selling, general & administrative increased 10.4%
Selling, general & administrative changed +10.4% from the comparable as-filed period.
$144.0M→$159.0M2 prior comparisons
SBC / revenue moved 49 bp lower
SBC / revenue changed -49 basis points from the comparable as-filed period.
1.98%→1.49%2 prior comparisons
Operating cash flow / net income decreased 1.0%
Operating cash flow / net income changed -1.0% from the comparable as-filed period.
0.97→0.962 prior comparisons
Gross debt decreased 24.9%
Gross debt changed -24.9% from the comparable as-filed period.
$5.1B→$3.9B2 prior comparisons
Inventory / revenue moved 1898 bp lower
Inventory / revenue changed -1898 basis points from the comparable as-filed period.
68.15%→49.16%0 prior comparisons
Debt / assets moved 2459 bp lower
Debt / assets changed -2459 basis points from the comparable as-filed period.
68.03%→43.44%2 prior comparisons
Total assets increased 17.6%
Total assets changed +17.6% from the comparable as-filed period.
$7.6B→$8.9B2 prior comparisons
Capital expenditure increased 274.4%
Capital expenditure changed +274.4% from the comparable as-filed period.
$43.0M→$161.0M0 prior comparisons
Cash / debt moved 1385 bp higher
Cash / debt changed +1385 basis points from the comparable as-filed period.
15.82%→29.67%1 prior comparisons
Operating cash-flow margin moved 2381 bp higher
Operating cash-flow margin changed +2381 basis points from the comparable as-filed period.
11.99%→35.80%0 prior comparisons
Operating cash flow / net income increased 95.5%
Operating cash flow / net income changed +95.5% from the comparable as-filed period.
0.76→1.490 prior comparisons
Receivables / revenue moved 967 bp higher
Receivables / revenue changed +967 basis points from the comparable as-filed period.
28.80%→38.46%0 prior comparisons
Debt / revenue moved 11411 bp lower
Debt / revenue changed -11411 basis points from the comparable as-filed period.
238.24%→124.13%0 prior comparisons
Free-cash-flow margin moved 2062 bp higher
Free-cash-flow margin changed +2062 basis points from the comparable as-filed period.
10.00%→30.62%0 prior comparisons
Working capital increased 21.6%
Working capital changed +21.6% from the comparable as-filed period.
$870.0M→$1.1B2 prior comparisons
Cost of revenue increased 18.9%
Cost of revenue changed +18.9% from the comparable as-filed period.
$1.4B→$1.7B0 prior comparisons
R&D / revenue moved 210 bp lower
R&D / revenue changed -210 basis points from the comparable as-filed period.
8.33%→6.23%0 prior comparisons
Current long-term debt changed across a zero base
Current long-term debt changed from 0 to 398000000 USD in the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
$0→$398.0M2 prior comparisons
SBC / revenue moved 76 bp lower
SBC / revenue changed -76 basis points from the comparable as-filed period.
2.50%→1.74%0 prior comparisons
Inventory increased 3.9%
Inventory changed +3.9% from the comparable as-filed period.
$1.5B→$1.5B2 prior comparisons
Research & development increased 7.8%
Research & development changed +7.8% from the comparable as-filed period.
$180.0M→$194.0M0 prior comparisons
Current ratio decreased 2.5%
Current ratio changed -2.5% from the comparable as-filed period.
1.36→1.332 prior comparisons
Working capital / assets moved 40 bp higher
Working capital / assets changed +40 basis points from the comparable as-filed period.
11.50%→11.90%2 prior comparisons
Selling, general & administrative increased 2.9%
Selling, general & administrative changed +2.9% from the comparable as-filed period.
$139.0M→$143.0M0 prior comparisons
Stock-based compensation unchangedd 0.0%
Stock-based compensation changed +0.0% from the comparable as-filed period.
$54.0M→$54.0M0 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.